Association of lymphocyte subsets percentage with prognosis for recurrent or metastatic nasopharyngeal carcinoma patients receiving PD-L1 inhibitors
Cancer Immunology, Immunotherapy · 2025
DOI: 10.1007/s00262-024-03885-1 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift Cancer Immunology, Immunotherapy, 2025. Verfasst von Jianming Diao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotherapy, Cancer Center, West China Hospital & State Key Laboratory of Biotherapy, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Nasopharyngeal Carcinoma, Immune Checkpoint Inhibitors, Nasopharyngeal Neoplasms, Lymphocyte Subsets. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotherapy, Cancer Center, West China Hospital & State Key Laboratory of Biotherapy, Sichuan University, Chengdu, China.
- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., Chengdu, China.
- Division of Abdominal Tumor Multimodality Treatment, Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China. 463527617@qq.com.
- Department of Biotherapy, Cancer Center, West China Hospital & State Key Laboratory of Biotherapy, Sichuan University, Chengdu, China. pxx2014@163.com.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Diao, J., Wei, Z., Pei, Y., Ge, J., Qing, Y., Wei, Y., Chen, Y., & Peng, X. (2025). Association of lymphocyte subsets percentage with prognosis for recurrent or metastatic nasopharyngeal carcinoma patients receiving PD-L1 inhibitors. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-024-03885-1
Vancouver
Diao J, Wei Z, Pei Y, Ge J, Qing Y, Wei Y, et al. Association of lymphocyte subsets percentage with prognosis for recurrent or metastatic nasopharyngeal carcinoma patients receiving PD-L1 inhibitors. Cancer Immunology, Immunotherapy. 2025. doi:10.1007/s00262-024-03885-1
BibTeX
@article{Diao2025,
author = {Diao, Jianming and Wei, Zhigong and Pei, Yiyan and Ge, Junyou and Qing, Yan and Wei, Youneng and Chen, Ye and Peng, Xingchen},
title = {Association of lymphocyte subsets percentage with prognosis for recurrent or metastatic nasopharyngeal carcinoma patients receiving PD-L1 inhibitors},
journal = {Cancer Immunology, Immunotherapy},
year = {2025},
doi = {10.1007/s00262-024-03885-1}
}
EUVIMED